Alpana Naresh, Ph.D.

VP, CMC Manufacturing at Hinge Bio, Inc.

Speaker

Alpana Naresh, Ph.D. is Vice President, CMC Manufacturing at Hinge Bio, Inc and responsible for manufacturing and CMC strategy for IND filing of Hinge Bio's novel tetravalent bispecific antibody with two Fc domains. Till recently, Alpana was Executive Director, CMC Operations at Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) and was responsible for managing development and manufacturing of Drug substance and Drug product at various CDMOs/CMOs and CROs. She was CMC lead through Merck's recent acquisition. Prior to joining Harpoon, Alpana was Principal Scientist at Boehringer Ingelheim, Fremont. Her team was responsible for development of Drug Substance for early- and late-stage products. She has also worked at JSR Life Sciences, Sutro Biopharma, and Genitope in various roles focused on process development of biotherapeutics.